Global Development VP — Clinical Strategy & Leadership

Initial Therapeutics, Inc.; Brisbane (CA); On-site; USD 350,000 - 600,000; Full time

Job summary

Nurix Therapeutics seeks a V.P./SVP, Global Development Leader to drive strategic medical leadership across phase 1–3 programs, ensuring safety, quality and regulatory alignment. This role reports to the Chief Medical Officer and leads cross-functional teams delivering program objectives.

The ideal candidate holds an MD with hematology/oncology board certification, 10+ years in clinical trials within pharma, and a proven ability to translate scientific insights into development plans.

Qualifications

• MD, board certified preferably in hematology/oncology.
• Requires at least 10 years’ clinical trial experience in the pharmaceutical industry with demonstrated involvement in Ph3 design or execution.
• Excellent communicator with leadership skills and ability to interact in cross-functional settings.

Responsibilities

• Lead one or more Program teams from Clinical Development, Research and Translational Medicine, Regulatory, and Quality from phase 1 through launch.
• Serve as single point of accountability for BTK Program Global Development Team and governance forums.
• Set direction with stakeholders and execute program strategy aligned with corporate goals.
• Drive development plans and ensure safety, regulatory compliance, and data interpretation across trials.
• Interact with principal investigators and opinion leaders to facilitate clinical trials research.
• Refine clinical development processes, data collection systems, and final reports.

Skills

Leadership

Clinical development

Cross-functional collaboration

Regulatory strategy

Education

MD, board certified in hematology/oncology

Job description

Nurix Therapeutics seeks a V.P./SVP, Global Development Leader to drive strategic medical leadership across phase 1–3 programs, ensuring safety, quality and regulatory alignment. This role reports to the Chief Medical Officer and leads cross-functional teams delivering program objectives.

The ideal candidate holds an MD with hematology/oncology board certification, 10+ years in clinical trials within pharma, and a proven ability to translate scientific insights into development plans.